Search clinical trials for: ATP III guidelines

Total 12203 results

Oslo University Hospital
University of Oslo

Unknown

Dietary Intervention in Follicular Lymphoma (KLYMF)

Follicular Lymphoma

Norway
University of Pittsburgh
Thrasher Research Fund

Completed

Guidelines for Acute Sinusitis

Sinusitis

United States
Biopure Corporation

Terminated

Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia

Peripheral Vascular Disease

United Kingdom, South Africa
Canadian Heart Research Centre
Merck Frosst Canada Ltd.; Schering-Plough

Completed

Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE ) (GUIDE)

Cardiovascular Diseases

Canada
St. Jude Children's Research Hospital

Completed

Large Cell Lymphoma Pilot Study III

Lymphoma, Non-Hodgkin | Lymphoma, Large Cell

United States
University of Brasilia

Completed

Isokinetic Testing Protocol in Elderly and Young Men

Healthy

Brazil
Charles University, Czech Republic

Unknown

AMAZING PRAGUE (PRAGUE-12) (AmP)

Atrial Fibrillation | Restore of Sinus Rhythm | Post-Operative Complications

Czech Republic
St. Jude Children's Research Hospital

Completed

Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma

Lymphoblastic Lymphoma

United States
Heidelberg University
University Hospital Muenster; University Hospital, Saarland; Lung Clinic Hemer; Kreiskrankenhaus Diekholzen and other collaborators

Completed

Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer
Aktion Bronchialkarzinom e.V.

Completed

Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.

Non-Small-Cell Lung Carcinoma

Germany
Norgine

Completed

A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution

Colonoscopy

Germany
Norgine

Completed

MOVIPREP® Versus NaP Pivotal Phase III Study

Colonoscopy

France
LivaNova

Completed

Clinical Evaluation on Advanced Resynchronization

Heart Failure | Cardiomyopathy

Netherlands, France, Spain, Italy, Germany, United Kingdom
Epimmune

Completed

An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer

Colorectal Neoplasms | Colonic Neoplasms

United States
Astellas Pharma Inc

Completed

Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis

Keratoconjunctivitis | Conjunctivitis

Japan
Sun Yat-sen University
Ministry of Health, China

Completed

Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma

Hepatocellular Carcinoma | Hepatectomy | Chemoembolization

China
Sanofi
Bristol-Myers Squibb

Completed

Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function

Peripheral Arterial Disease

Hungary
Weill Medical College of Cornell University

Completed

Hospital Outcomes: Intervention in Moderately III Patients

Moderately Ill Medical Inpatients at the Cornell Campus of the New York-Presbyterian Hospital

United States
Advanz Pharma
Astellas Pharma US, Inc.

Completed

A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter (Scene 2)

Atrial Flutter

United States, Canada, Denmark, Sweden
Advanz Pharma
Astellas Pharma US, Inc.

Completed

Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation (ACT I)

Atrial Fibrillation

United States, Canada, Sweden, Denmark
Abbott

Completed

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

HIV Infections

France, Spain, United States, Canada, Poland, Argentina, Brazil, Germany, Italy, Puerto Rico, United Kingdom
Medical University of Vienna

Completed

Effect of Virtual Endoscopy Simulator Training on Real Patient Endoscopy (endosim)

Pain

Austria
Newron Pharmaceuticals SPA

Completed

Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist

Idiopathic Parkinson's Disease
Newron Pharmaceuticals SPA

Completed

Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)

Parkinson's Disease
AZ-VUB
Sanofi

Unknown

Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

Non-Small-Cell Lung Carcinoma

Belgium
Dey

Completed

A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD

COPD

United States
National Institute of Allergy and Infectious Diseases...

Completed

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Mycoses

United States
National Cancer Institute (NCI)

Completed

A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma

Melanoma

United States
National Cancer Institute (NCI)

Completed

A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients

Breast Cancer | Breast Neoplasms

United States
National Institute of Allergy and Infectious Diseases...

Completed

Valaciclovir to Prevent Transmission of Herpes Simplex Virus

Herpes Simplex

United States
National Cancer Institute (NCI)

Completed

Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
National Cancer Institute (NCI)

Completed

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Mycoses | Candidiasis | Fungemia | Aspergillosis

United States
National Cancer Institute (NCI)

Completed

Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer

Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

Sepsis | Hematologic Diseases | Breast Neoplasms | Neutropenia | Fever

United States
National Cancer Institute (NCI)

Completed

Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines

HIV Infections | Healthy

United States
National Cancer Institute (NCI)

Completed

Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study

Osteosarcoma

United States
National Cancer Institute (NCI)

Completed

A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer

Breast Neoplasms | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
Carlos III Health Institute
Public Health Service of Madrid; Agencia Lain Entralgo

Completed

Efficiency of GDS Method for Lumbar Stabilization for Non-Specific Low Back Pain in Primary Care (GDS)

Low Back Pain

Spain
Novartis

Completed

Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.

Chronic Constipation
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Lung Cancer

United States
Novartis

Completed

Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance

Renal Transplantation

United States
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer

Breast Cancer

Greece
Kaunas University of Medicine

Unknown

Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer

Primary Rectal Cancer

Lithuania
Umeå University

Unknown

Bi-Ventricular Pacing in Patients With Atrial Fibrillation and Heart Failure (BIFF-Study) (BIFF)

Heart Failure

Sweden
Medical University of Vienna

Completed

Gastric pH in Critically Ill Patients

Critically Ill Patients | Indication for Stress Ulcer Prophylaxis

Austria
Hospital of Navarra
Dr. Enrique Martínez López

Unknown

Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Spain
University Hospital, Ghent

Completed

Prosthetic Component Relationship of the Reversed Delta III Total Shoulder Prosthesis in the Transverse Plane of the Body

Shoulder Prosthesis

Belgium
Medtronic Cardiac Rhythm and Heart Failure

Completed

InSync III Marquis Model 7279 Cardioverter Defibrillator Cardiac Resynchronization System

Heart Failure

United States
Unither Pharmaceuticals

Terminated

Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma

Ovarian Neoplasms

Canada, United States

3

Subscribe